Skip to main content

Advertisement

SpringerLink
Log in

Detrusor Underactivity and Detrusor Hyperactivity with Impaired Contractility

  • Geriatric Bladder Dysfunction (G Ghoniem, Section Editor)
  • Published:
Current Bladder Dysfunction Reports Aims and scope Submit manuscript

Abstract

Detrusor underactivity (DU) is a condition of impaired bladder contraction strength or duration resulting in impaired bladder emptying. In contrast, detrusor hyperactivity with impaired contractility (DHIC) is a condition in which patients paradoxically exhibit detrusor overactivity during storage yet are unable to mount a sufficient detrusor contraction during voiding to completely empty the bladder. Both conditions are often mistaken for bladder outlet obstruction. These conditions are more commonly seen in institutionalized elderly patients with either urinary retention or incontinence. To date, the exact etiologies of DU and DHIC remain unclear. Accurate diagnosis is based on clinical suspicion, complete history and physical exam, and videourodynamic evaluation. However, in certain patients, such as frail elderly patients, a full workup may not be warranted if it will not influence treatment decisions. Treatment of these disorders is primarily based on patient bother, with behavior modification first implemented, followed by pharmacotherapy with addition of CIC or indwelling catheter as indicated.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance

  1. Abrams P, Cardozo L, Fall M, Griffiths D, Rosier P, Ulmsten U, et al. The standardisation of terminology in lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society. Urol. 2003;61:37–49.

    Article  PubMed  Google Scholar 

  2. Abraham N, Goldman HB. Detrusor underactivity. AUA Updat Ser. 2014;33:114–9.

    Google Scholar 

  3. van Koeveringe GA, Vahabi B, Andersson KE, Kirschner-Herrmans R, Oelke M. Detrusor underactivity: a plea for new approaches to a common bladder dysfunction. Neurourol Urodyn. 2011;30:723–8.

    Article  PubMed  Google Scholar 

  4. Thomas AW, Cannon A, Bartlett E, Ellis-Jones J, Abrams P. The natural history of lower urinary tract dysfunction in men: the influence of detrusor underactivity on the outcome after transurethral resection of the prostate with a minimum 10-year urodynamic follow-up. BJU Int. 2004;93:745–50.

    Article  CAS  PubMed  Google Scholar 

  5. de Groat WC, Booth AM, et al. Neurophysiology of micturition and its modification in animal models of human disease. The autonomic nervous system. London: Harwood Acad Publishers. 1993;1:227–90.

    Google Scholar 

  6. Dupont M, Steers WD, et al. Neural plasticity and alterations in nerve growth factor norepinephrine in response to bladder inflammation. J Urol. 1994; 151.

  7. Wilson TS. Incontinence of urine in the aged. Lancet. 1948;251:374–8.

    Article  Google Scholar 

  8. Resnick NM, Yalla SV. Detrusor hyperactivity with impaired contractile function: an unrecognized by common cause of incontinence in elderly patients. JAMA. 1987;257:3076–81.

    Article  CAS  PubMed  Google Scholar 

  9. Yalla SV, Sullivan MP, Resnick NM. Update on detrusor hyperactivity with impaired contractility. Curr Bladder Dysfunct Rep. 2007;2:191–6.

    Article  Google Scholar 

  10. Cucchi A, Quaglini S, Rovereto B. Proposal for a urodynamic redefinition of detrusor underactivity. J Urol. 2009;181:225–9.

    Article  PubMed  Google Scholar 

  11. Lee WC, Wu HP, Tai TY, Yu HJ, Chiang PH. Investigation of urodynamic characteristics ad bladder sensory function in the early stages of diabetic bladder dysfunction in women with type 2 diabetes. J Urol. 2009;181:198–203.

    Article  PubMed  Google Scholar 

  12. Suskind AM, Smith PP. A new look at detrusor underactivity: impaired contractility versus afferent dysfunction. Curr Urol Rep. 2009;10:347–51.

    Article  PubMed  Google Scholar 

  13. Gilpin SA, Gilpin CJ, Dixon JS, Gosling JA, Kirby RS. The effect of age on the autonomic innervation of the urinary bladder. Br J Urol. 1986;58:378–81.

    Article  CAS  PubMed  Google Scholar 

  14. Miyazato M, Yoshimura N, Chancellor MB. The other bladder syndrome: underactive bladder. Rev Urol. 2013;15:11–22.

    PubMed Central  PubMed  Google Scholar 

  15. Kirschner-Hermanns R, Daneshgari F, Vahabi B, Birder L, Oelke M, Chacko S. Does diabetes mellitus-induced bladder remodeling affect lower urinary tract function? ICI-RS 2011. Neurourol Urodyn. 2012;31:359–64.

    Article  PubMed  Google Scholar 

  16. Thomas AW, Cannon A, Bartlett E, Ellis-Jones J, Abrams P. The natural history of lower urinary tract dysfunction in men: minimum 10-year follow-up of untreated bladder outlet obstruction. BJU Int. 2005;96:1301–6.

    Article  PubMed  Google Scholar 

  17. Bansal R, Agarwal MM, Modi M, Mandal AK, Singh SK. Urodynamic profile of diabetic patients with lower urinary tract symptoms: association of diabetic cystopathy with autonomic and peripheral neuropathy. Urol. 2011;77:699–705.

    Article  PubMed  Google Scholar 

  18. Lange MM, van de Velde CJ. Urinary and sexual dysfunction after rectal cancer treatment. Nat Rev Urol. 2011;8:51–7.

    Article  PubMed  Google Scholar 

  19. Kim DK, Chancellor MB. Pathophysiology of detrusor underactivity/acontractile detrusor. Textbook of the Neurogenic Bladder Second Ed. 2008;12:182–93.

    Article  Google Scholar 

  20. Drake MJ, Harvey IJ, Gillespie JI, Van Duyl WA. Localized contractions in the normal human bladder and in urinary urgency. BJU Int. 2005;95:1002–5.

    Article  PubMed  Google Scholar 

  21. Taylor JA, Kuchel GA. Detrusor underactivity: clinical features and pathogenesis of an underdiagnosed geriatric condition. J Am Geriatr Soc. 2006;54:1920–32.

    Article  PubMed  Google Scholar 

  22. Buttyan R, Chen MW, Levin RM. Animal models of bladder outlet obstruction and molecular insights into the basis for the development of bladder dysfunction. Eur Urol. 1997;32:32–9.

    CAS  PubMed  Google Scholar 

  23. Gosling JA, Kung LS, Dixon JS, Horan P, Whitbeck C, Levin RM. Correlation between the structure and function of the rabbit urinary bladder following partial outlet obstruction. J Urol. 2000;163:1349–56.

    Article  CAS  PubMed  Google Scholar 

  24. Gabella G, Uvelius B. Reversal of muscle hypertrophy in the rat urinary bladder after removal of urethral obstruction. Cell Tissue Res. 1994;277:333–9.

    Article  CAS  PubMed  Google Scholar 

  25. Lepor H, Sunaryadi I, Hartanto V, Shapiro E. Quantitative morphometry of the adult human bladder. J Urol. 1992;148:414–7.

    CAS  PubMed  Google Scholar 

  26. Schneider T, Hein P, Bai J, Michel MC. A role for muscarinic receptors or rho-kinase in hypertension associated rat bladder dysfunction? J Urol. 2005;173:2178–81.

    Article  CAS  PubMed  Google Scholar 

  27. Kuchel GA. Aging and homeostatic regulation. Hazzard’s Geriatric Medicine and Gerontology. 6th ed. New York: McGraw-Hill; 2009. p. 621–30.

    Google Scholar 

  28. Elbadawi A, Yalla SV, Resnick NM. Structural basis of geriatric voiding dysfunction. II. Aging detrusor: normal versus impaired contractility. J Urol. 1993;150:1657–67.

    CAS  PubMed  Google Scholar 

  29. Lluel P, Palea S, Ribiere P, Barras M, Teillet L, Corman B. Increased adrenergic contractility and decreased mRNA expression of NOS III in aging rat urinary bladders. Fundam Clin Pharmacol. 2003;17:633–41.

    Article  CAS  PubMed  Google Scholar 

  30. Cucchi A, Quaglini S, Guarnaschelli C, Rovereto B. Urodynamic findings suggesting two-stage development of idiopathic detrusor underactivity in adult men. Urol. 2007;70:75–9.

    Article  PubMed  Google Scholar 

  31. Griffiths DJ, McCracken PN, Harrison GM, Gormley EA, Moore KN. Urge incontinence and impaired detrusor contractility in the elderly. Neurourol Urodyn. 2002;21:126–31.

    Article  PubMed  Google Scholar 

  32. Elbadawi A, Yalla SV, Resnick NM. Structural basis of geriatric voiding dysfunction. III. Detrusor overactivity. J Urol. 1993;150:1668–80.

    CAS  PubMed  Google Scholar 

  33. Tyagi P, Tyagi V, Qu X, Lin HT, Kuo HC, Chuang YC, et al. Association of inflammaging (inflammation + aging) with higher prevalence of OAB in elderly population. Int Urol Nephrol. 2014;46:871–7. Urinary markers of inflammation (NGF and MCP-1) are elevated in patients with OAB. Chronic inflammation leads to muscle wasting/sarcopenia, which have been postulated to assist in progression of OAB into DHIC.

    Article  CAS  PubMed  Google Scholar 

  34. Ghoniem G, Faruqui N, Elmissiry M, Mahdy A, Abdelwahab H, Oommen M, et al. Differential profile analysis of urinary cytokines in patients with overactive bladder. Int Urogynecol J. 2011;22:953–61.

    Article  PubMed  Google Scholar 

  35. Lai HH, Boone TB, Thompson TC, Smith CP, Somogyi GT. Using caveolin-1 knockout mouse to study impaired detrusor contractility and disrupted muscarinic activity in the aging bladder. Urol. 2007;69:407–11.

    Article  PubMed  Google Scholar 

  36. D’Agostino G, Condino AM, Calvi V, Boschi F, Gioglio L, Barbieri A. Purinergic P2X3 heteroreceptors enhance parasympathetic motor drive in isolated porcine detrusor, a reliable model for development of P2X selective blockers for detrusor hyperactivity. Pharmacol Res. 2012;65:129–36. Down-regulated P2X3 subunits may be activated by endogenous ATP, enhancing detrusor contractility or overactivity. Extrapolation to humans have yet to be made.

    Article  PubMed  Google Scholar 

  37. Zhu Q, Ritchie J, Marouf N, Dion SB, Resnick NM, Elbadawi A, et al. Role of ovarian hormones in the pathogenesis of impaired detrusor contractility: evidence in ovariectomized rodents. J Urol. 2001;166:1136–41.

    Article  CAS  PubMed  Google Scholar 

  38. Ghoniem GM, Regnier CH, Biancani P, Susset JG. Effect of diethylstilbestrol on bladder contractility in male rats. J Urol. 1983;129:865–8.

    CAS  PubMed  Google Scholar 

  39. Azadzoi KM, Tarcan T, Kozlowski R, Siroky MB. Overactivity and structural changes in the chronically ischemic bladder. J Urol. 1999;162:1768–78.

    Article  CAS  PubMed  Google Scholar 

  40. Smith PP. Aging and the underactive detrusor: a failure of activity or activation? Neurourol Urodyn. 2010;29:408–12.

    PubMed  Google Scholar 

  41. Resnick NM, Yalla SV, Laurino E. The pathophysiology of urinary incontinence among institutionalized elderly persons. NEJM. 1989;320:1–7.

    Article  CAS  PubMed  Google Scholar 

  42. Jeong SJ, Kim HJ, Lee YJ, Lee JK, Lee BK, Choo YM, et al. Prevalence and clinical features of detrusor underactivity among elderly with lower urinary tract symptoms: a comparison between men and women. Korean J Urol. 2012;53:342–8.

    Article  PubMed Central  PubMed  Google Scholar 

  43. Abarbanel J, Marcus E. Impaired detrusor contractility in community-dwelling elderly presenting with lower urinary tract symptoms. Urol. 2007;69:436–40.

    Article  PubMed  Google Scholar 

  44. Valentini FA, Robain G, Marti BG, Nelson PP. Urodynamics in a community-dwelling population of females 80 years or older. Which motive? Which diagnosis? Int Braz J Urol. 2010;36:218–24.

    Article  PubMed  Google Scholar 

  45. Miu DKY, Lau S, Szeto SSL. Etiology and predictors of urinary incontinence and its effect on quality of life. Geriatr Gerontol Int. 2010;10:177–82.

    PubMed  Google Scholar 

  46. Yamamoto T, Sakakibara R, Uchiyama T, Liu Z, Ito T, Awa Y, et al. Neurological diseases that cause detrusor hyperactivity with impaired contractile function. Neurourol Urodyn. 2006;25:356–60.

    Article  PubMed  Google Scholar 

  47. Resnick NM, Brandeis GH, Baumann MM, DuBeau CE, Yalla SV. Misdiagnosis of urinary incontinence in nursing home women: prevalence and a proposed solution. Neurourol Urodyn. 1996;15:599–618.

    Article  CAS  PubMed  Google Scholar 

  48. Tan TL, Bergmann MA, Griffiths D, Resnick NM. Which stop test is best? Measuring detrusor contractility in older females. J Urol. 2003;169:1023–7.

    Article  PubMed  Google Scholar 

  49. Sullivan MP, DuBeau CE, Resnick NM, Cravalho EG, Yalla SV. Continuous occlusion test to determine detrusor contractile performance. J Urol. 1995;154:1834–40.

    Article  CAS  PubMed  Google Scholar 

  50. Ameda K, Sullivan MP, Bae RJ, Yalla SV. Urodynamic characterization of nonobstructive voiding dysfunction in symptomatic elderly men. J Urol. 1999;162:142–6.

    Article  CAS  PubMed  Google Scholar 

  51. Griffiths D, van Mastrigt R, Bosch R. Quantification of urethral resistance and bladder function during voiding, with special reference to the effects of prostate size reduction on urethral obstruction due to benign prostatic hyperplasia. Neurourol Urodyn. 1989;8:17–27.

    Article  Google Scholar 

  52. Griffiths DJ, Scholtmeijer RJ. Vesicoureteral reflux and lower urinary tract dysfunction: evidence for 2 different reflux/dysfunction complexes. J Urol. 1987;137:240–4.

    CAS  PubMed  Google Scholar 

  53. Schafer W. Analysis of bladder-outlet function with the linearized passive urethral resistance relation, linPURR, and a disease-specific approach for grading obstruction: from complex to simple. World J Urol. 1995;13:47–58.

    Article  CAS  PubMed  Google Scholar 

  54. Schafer W. The contribution of the bladder outlet to the relation between pressure and flow rate during micturition. Benign Prostatic Hypertrophy. New York: Springer; 1983. p. 470–796.

    Google Scholar 

  55. Schafer W. Principles and clinical application of advanced urodynamic analysis of voiding function. Urol Clin North Am. 1990;17:553–66.

    CAS  PubMed  Google Scholar 

  56. Abrams P. Bladder outlet obstruction index, bladder contractility index and bladder voiding efficiency: three simple indices to define bladder voiding function. BJU Int. 1999;84:14–5.

    Article  CAS  PubMed  Google Scholar 

  57. Imran M, Najmi AK, Tabrez S. Mirabegron for overactive bladder: a novel, first-in-class B3-agonist therapy. Urol J. 2013;10:935–40.

    PubMed  Google Scholar 

  58. Wagg A, Cardozo L, Nitti VW, Castro-Diaz D, Auerbach S, Blauwet MB, Siddiqui E. The efficacy and tolerability of the B3-adrenoceptor agonist mirabegron for the treatment of symptoms of overactive bladder in older patients. Age and Ageing. 2014:1–10. Subanalysis from data collected during safety and Phase III trials of Mirabegron show it is well tolerated in patients >65 and >75 yrs

  59. Duthie JB, Vincent M, Herbison GP, Wilson DI, Wilson D. Botulinum toxin injections for adults with overactive bladder syndrome. Cochrane Database Syst Rev. 2011;7(12):CD5493. Review of use of intravesical botulinum toxin versus other treatments for overactive bladder in adults.

    Google Scholar 

  60. Barendrecht MM, Oelke M, Laguna MP, Michel MC. Is the use of parasympathomimetics for treating an underactive urinary bladder evidence-based? BJU Int. 2007;99:749–52.

    Article  CAS  PubMed  Google Scholar 

  61. Andersson KE, Appell R, Cardozo L, Chapple C. Pharmacological treatment of urinary incontinence. Incontinence, 3rd International Consultation on Incontinence. 2005:811.

  62. Everaerts W, Gevaert T, Nilius B, De Ridder D. On the origin of bladder sensing: Tr(i)ps in urology. Neurourol Urodyn. 2008;27:264–73.

    Article  CAS  PubMed  Google Scholar 

  63. Andersson KE, Arner A. Urinary bladder contraction and relaxation: physiology and pathophysiology. Physiol Rev. 2004;84:935–86.

    Article  CAS  PubMed  Google Scholar 

  64. Andersson KE, Gratzke C, Hedlund P. The role of the transient receptor potential (TRP) superfamily of cation-selective channels in the management of the overactive bladder. BJU Int. 2010;106:1114–27.

    Article  CAS  PubMed  Google Scholar 

  65. Andersson KE, Wein AJ. Pharmacology of the lower urinary tract: basis for current and future treatments of urinary incontinence. Pharmacol Rev. 2004;56:581–631.

    Article  CAS  PubMed  Google Scholar 

  66. Wyndaele JJ. Complications of intermittent catheterization: their prevention and treatment. Spinal Cord. 2002;40:536–41.

    Article  CAS  PubMed  Google Scholar 

  67. Perrouin-Verbe B, Labat JJ, Richard I, de la Greve Mauduyt I, Buzelin JM, Mathe JF. Clean intermittent catheterisation from the acute period in spinal cord injury patients. Long term evaluation of urethral and genital tolerance. Paraplegia. 1995;33:619–24.

    Article  CAS  PubMed  Google Scholar 

  68. Brindley GS, Polkey CE, Rushton DN, Cardozo L. Sacral anterior root stimulators for bladder control in paraplegia: the first 50 cases. J Neurol Neurosurg Psychiatry. 1986;49:1104–14.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  69. Katona F, Eckstein HB. Treatment of neuropathic bladder by transurethral electrical stimulation. Lancet. 1974;1:780–1.

    Article  CAS  PubMed  Google Scholar 

  70. van Kerrebroek PE, van Voskuilen AC, Heesakkers JP, Nijholt AA L a, Siegel S, Jonas U, et al. Results of sacral neuromodulation therapy for urinary voiding dysfunction: outcomes of a prospective, worldwide clinical study. J Urol. 2007;178:2029–34.

    Article  Google Scholar 

  71. Stenzl A, Ninkovic M, Koole D, Knapp R, Anderl H, Bartsch G. Restoration of voluntary emptying of the bladder by transplantation of innervated free skeletal muscle. Lancet. 1998;351:1483–5.

    Article  CAS  PubMed  Google Scholar 

  72. Gaskis G, Ninkovic M, van Koeveringe GA, Raina S, Sturtz G, Rahnama’i MS, et al. Functional detrusor myoplasty for bladder acontractility: long-term results. J Urol. 2011;185:593–9. Latissimus dorsi detrusor myoplasty is an effective alternative to clean intermittent catheterization in a select group of patients with neurogenic bladder acontractility.

    Article  Google Scholar 

  73. Stanasel I, Mirzazadeh M, Smith 3rd JJ. Bladder tissue engineering. Urol Clin North Am. 2010;37:593–9.

    Article  PubMed  Google Scholar 

Download references

Compliance with Ethics Guidelines

Conflict of Interest

Christopher T. Brown and Sylvester Onyishi declare no conflicts of interest.

Christian O. Twiss declares financial association with Astellas, Inc.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Author information

Authors and Affiliations

  1. Department of Surgery, Section of Urology, University of Arizona Medical Center, 1501 N. Campbell Avenue, P.O. BOX 245077, Tucson, AZ, 85724-5077, USA

    Christopher T. Brown, Sylvester Onyishi & Christian O. Twiss

Authors
  1. Christopher T. Brown
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sylvester Onyishi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Christian O. Twiss
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Christian O. Twiss.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Brown, C.T., Onyishi, S. & Twiss, C.O. Detrusor Underactivity and Detrusor Hyperactivity with Impaired Contractility. Curr Bladder Dysfunct Rep 9, 341–349 (2014). https://doi.org/10.1007/s11884-014-0260-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11884-014-0260-9

Keywords

Search

Navigation